Impact of comorbidity and relative dose intensity on outcomes in diffuse large B-cell lymphoma patients treated with R-CHOP

Journal of Cancer Research and Clinical Oncology
Masakazu YamamotoKatsushi Tajima

Abstract

Comorbidity and relative dose intensity (RDI) have been associated with survival in diffuse large B-cell lymphoma (DLBCL) patients, but both relationships remain unaddressed in the same patients. A retrospective review of consecutive DLBCL patients treated from January 2010 to October 2018 was performed. Data for the clinical characteristics of the patients, including the Charlson Comorbidity Index (CCI) and RDI, on their outcomes were evaluated. A total of 211 patients with a median age of 72 years (range 19-90 years) were analyzed. CCI ≥ 2 was associated with poor event-free survival (EFS) and overall survival (OS). RDI < 70% was associated with worse EFS and OS. A multivariate analysis revealed that RDI < 70% was only a poor risk factor for the reduction of OS in elderly DLBCL patients (65 years <) and independent from the presence of CCI. The relationship between CCI and RDI in elderly patients was analyzed in four groups, based on CCI ≥ 2 or less and RDI ≥ 70% or less. The group with CCI ≥ 2 and RDI < 70% had a poorer OS and EFS, as compared to the other three groups. The group with CCI < 2 and RDI ≥ 70% had a superior OS but an identical EFS, as compared to the two groups with CCI < 2 and RDI < 70% and CCI ≥ 2 and RDI ≥ 7...Continue Reading

References

Aug 20, 2009·Journal of Experimental & Clinical Cancer Research : CR·Yoshiki TeradaMasayuki Hino
Oct 30, 2010·CA: a Cancer Journal for Clinicians·Christopher R FlowersJulie M Vose
Apr 13, 2011·The Lancet Oncology·Frédéric PeyradeUNKNOWN Groupe d'Etude des Lymphomes de l'Adulte (GELA) investigators
Apr 3, 2012·British Journal of Haematology·Paul A Fields, David C Linch
Oct 16, 2015·[Rinshō ketsueki] The Japanese journal of clinical hematology·Yoshinobu Kanda
Jan 21, 2017·British Journal of Haematology·Carlos MontalbánUNKNOWN GELTAMO-IPI Project Investigators
Apr 15, 2017·The Oncologist·Katsuhiro MiuraMasatoshi Kanno
Jun 15, 2017·American Journal of Hematology·Caner SayginDeepa Jagadeesh
Feb 25, 2018·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Tarec Christoffer El-GalalyDiego Villa

❮ Previous
Next ❯

Citations

May 8, 2021·Blood Advances·Edward J BataillardTarec Christoffer El-Galaly
Jun 12, 2021·Expert Review of Anticancer Therapy·Michelle ShayneGary H Lyman

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.